Middle East And Africa Pen Needles Market Report

Middle East and Africa Pen Needles Market Size

The Middle East and Africa pen needles market size was valued at USD 0.39 billion in 2025 and is anticipated to reach USD 0.43 billion in 2026 from USD 0.97 billion by 2034, growing at a CAGR of 10.77% during the forecast period from 2026 to 2034.

Pen needles are used to deliver the medication (such as insulin or other injectable medications) combined with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are mainly utilized by diabetes patients.

Growing annual health care expenditure, increasing public & private organizations' involvement in diabetes awareness programs, and rising demand for advanced insulin delivery devices drive the growth of the Middle East & Africa pen needles market. However, limited accessibility of pen needles and lack of health care infrastructure & outdated facilities are restraining the growth of the Middle East & Africa pen needles market.

KEY MARKET PLAYERS

Companies leading the MEA Pen Needles Market include

• Becton, Dickinson and Company (U.S.)
• Novo Nordisk A/S (Denmark)
• Ypsomed Holding AG (Switzerland)
• UltiMed, Inc. (U.S.)
• Allison Medical, Inc. (U.S.)
• Owen Mumford, Ltd. (U.K.)
• B. Braun Melsungen AG (Germany)
• Artsana S.p.A. (Italy)
• HTL-STREFA S.A. (Poland)
• Terumo Corporation (Japan)
• Others

MARKET SEGMENTATION

This research report on the Middle East and Africa Pen Needles Market has been segmented and sub-segmented into the following categories

By Therapy

• Insulin Therapy
• GLP-1 Therapy
• Growth Hormone Therapy

By Type

• Standard Needle
• Safety Needle

By Needle Length

• 4mm
• 6mm
• 8mm
• 10mm
• 12mm

By Mode of Purchase

• Retail
• Non-Retail

By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA